Avalo Therapeutics (AVTX) Capital Expenditures (2016 - 2023)

Avalo Therapeutics' (AVTX) quarterly Capital Expenditures came in at $158000.0 in Q1 2023, up 66.32% on a QoQ basis from $95000.0 in Q4 2022.

Avalo Therapeutics (AVTX) Capital Expenditures (2016 - 2023) Analysis & Trends

Avalo Therapeutics (AVTX) has 8 years of Capital Expenditures data on file, last reported at $158000.0 in Q1 2023.

Quarterly Capital Expenditures changed N/A year-over-year to $158000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $158000.0 (up 66.32% YoY) and the FY2023 annual result came in at $158000.0, up 66.32% from the prior year.
Capital Expenditures grew to $158000.0 in Q1 2023, from $95000.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $2.0 million in Q3 2021 to a low of -$1.0 million in Q4 2021.
A 5-year average of $131501.1 and a median of $59500.0 in 2020 frame the typical range for Capital Expenditures.
Annual changes were most pronounced in 2020 — Capital Expenditures soared 3149900.0% — and 2021, when it sank 1687.3%.
Tracing AVTX's Capital Expenditures over 5 years: stood at $2.0 in 2019, then soared by 3149900.0% to $63000.0 in 2020, then slumped by 1687.3% to -$1.0 million in 2021, then surged by 109.5% to $95000.0 in 2022, then jumped by 66.32% to $158000.0 in 2023.
The last three Capital Expenditures figures came in at $158000.0 (Q1 2023), $95000.0 (Q4 2022), and -$56000.0 (Q3 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.29 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.02 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	572,662.23
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	251.02 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	34.68 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.26 Mn
10	Avalo Therapeutics	854.16 Mn	453.89 Mn	-	-

Download Data